» Articles » PMID: 22509021

Induction of MicroRNA-155 is TLR- and Type IV Secretion System-dependent in Macrophages and Inhibits DNA-damage Induced Apoptosis

Overview
Specialty Science
Date 2012 Apr 18
PMID 22509021
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori is a gastric pathogen responsible for a high disease burden worldwide. Deregulated inflammatory responses, possibly involving macrophages, are implicated in H. pylori-induced pathology, and microRNAs, such as miR-155, have recently emerged as crucial regulators of innate immunity and inflammatory responses. miR-155 is regulated by Toll-like receptor (TLR) ligands in monocyte-derived cells and has been shown to be induced in macrophages during H. pylori infection. Here, we investigated the regulation of miR-155 expression in primary murine bone marrow-derived macrophages (BMMs) during H. pylori infection and examined the downstream mRNA targets of this microRNA using microarray analysis. We report TLR2/4- and NOD1/2-independent up-regulation of miR-155, which was found to be dependent on the major H. pylori pathogenicity determinant, the type IV secretion system (T4SS). miR-155 expression was dependent on NF-κB signaling but was independent of CagA. Microarray analysis identified known gene targets of miR-155 in BMMs during H. pylori infection that are proapoptotic. We also identified and validated miR-155 binding sites in the 3' UTRs of the targets, Tspan14, Lpin1, and Pmaip1. We observed that H. pylori-infected miR-155(-/-) BMMs were significantly more susceptible to cisplatin DNA damage-induced apoptosis than were wild-type BMMs. Thus, our data suggest a function for the prototypical H. pylori pathogenicity factor, the T4SS, in the up-regulation of miR-155 in BMMs. We propose the antiapoptotic effects of miR-155 could enhance macrophage resistance to apoptosis induced by DNA damage during H. pylori infection.

Citing Articles

Non-coding RNA Networks in Infection.

Janga H, Schmerer N, Aznaourova M, Schulte L Methods Mol Biol. 2024; 2883:53-77.

PMID: 39702704 DOI: 10.1007/978-1-0716-4290-0_3.


A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.


The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori.

Liu M, Hu Z, Wang C, Zhang Y J Mol Med (Berl). 2023; 101(7):767-781.

PMID: 37195446 DOI: 10.1007/s00109-023-02332-5.


Saliva microRNA Profile in Children with and without Severe SARS-CoV-2 Infection.

Hicks S, Zhu D, Sullivan R, Kannikeswaran N, Meert K, Chen W Int J Mol Sci. 2023; 24(9).

PMID: 37175883 PMC: 10179619. DOI: 10.3390/ijms24098175.


The Role of miR-155 in Antitumor Immunity.

Kalkusova K, Taborska P, Stakheev D, Smrz D Cancers (Basel). 2022; 14(21).

PMID: 36358832 PMC: 9659277. DOI: 10.3390/cancers14215414.


References
1.
Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M . Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res. 2006; 66(19):9557-65. DOI: 10.1158/0008-5472.CAN-06-1131. View

2.
Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

3.
Lonkar P, Dedon P . Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer. 2011; 128(9):1999-2009. PMC: 3334345. DOI: 10.1002/ijc.25815. View

4.
Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A . Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 2009; 5(10):e1000603. PMC: 2745580. DOI: 10.1371/journal.ppat.1000603. View

5.
Yunta M, Lazo P . Apoptosis protection and survival signal by the CD53 tetraspanin antigen. Oncogene. 2003; 22(8):1219-24. DOI: 10.1038/sj.onc.1206183. View